Transcriptomics

Dataset Information

BET inhibitor Pelabresib and AR inhibitor enzalutamide perturbed pathways in prostate cancer CRPC PDX LuCaP 35CR


ABSTRACT: To study the effect of inhibiting AR and HNF1A/HNF4G activity either alone or in combination on the growth of CRPC PDX LuCaP 35CR

ORGANISM(S): Homo sapiens

PROVIDER: GSE254665 | GEO | 2025/01/18

REPOSITORIES: GEO